From: Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling
Cohort
GSE10846
GSE23501
N. of cases
233
64
Sex (% male)
57.50
71.87
Median Age
61.0
63.5
Median follow-up time (years)
2.12
2.24
COO
GCB
45.90%
57.81%
ABC
39.90%
29.69%
NC
14.20%
12.50%